Peptides present unique analytical challenges. They are large, complex molecules with many possible synthesis errors — incomplete sequences, deletions, oxidation, racemization, and residual protecting groups can all produce impurities that are invisible to the naked eye and undetectable without laboratory instrumentation. A peptide can look, smell, and dissolve identically to a pure sample while being significantly impure.
The two primary methods for peptide purity analysis are HPLC and mass spectrometry. They measure fundamentally different things, and together they provide complete analytical coverage.
What it measures: the relative quantity of each component in the sample — expressed as a purity percentage.
How it works: the peptide sample is dissolved and injected into the HPLC system. A mobile phase carries the sample through a column packed with stationary-phase material. Different compounds interact with the stationary phase differently, causing them to separate. A UV or DAD detector measures absorbance as each component elutes, producing a chromatogram with peaks. The area under each peak is proportional to the quantity of that compound.
What it measures: the molecular mass of the compound — used to confirm its identity with certainty.
How it works: in liquid chromatography–mass spectrometry (LC-MS), the peptide is ionized and its mass-to-charge ratio (m/z) is measured. For a peptide, this confirms the molecular weight to within a fraction of a Dalton — a precise match to the theoretical mass of the claimed compound. Tandem MS (MS/MS) fragments the peptide and analyzes the fragments, enabling sequence confirmation.
HPLC and mass spectrometry are complementary, not interchangeable:
Gold Standard Analytics runs both methods on every sample as standard practice — not as an upsell. Any lab that offers only HPLC or only mass spec is providing an incomplete analysis.
A COA showing 98 % purity by HPLC and correct identity by MS still doesn’t tell you the true active dose per milligram. That requires Net Peptide Content (NPC) testing.
Research peptides typically contain trifluoroacetic acid (TFA) counter-ions, moisture, and other non-peptide mass. A vial labeled “10 mg” may contain only 6–8 mg of actual active peptide — the rest is TFA and water. NPC quantifies the actual peptide mass as a percentage of total sample weight, allowing accurate dosing.
Read more about peptide testing scope on our peptide-testing service page — it covers research peptides, the full GLP-1 class (Semaglutide, Tirzepatide, Retatrutide, Cagrilintide), and USP <85> endotoxin / USP <71> sterility for injectable-grade vials on a single COA.